These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35422184)

  • 1. Utility of tocilizumab in autoimmune eye diseases.
    Atienza-Mateo B; Prieto-Peña D; Vicente-Rabaneda EF; Blanco R; González-Gay MA; Castañeda S
    Expert Opin Biol Ther; 2022 Jun; 22(6):789-799. PubMed ID: 35422184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
    Pascual-Camps I; Molina-Pallete R; Bort-Martí MA; Todolí J; España-Gregori E
    Orbit; 2018 Dec; 37(6):450-453. PubMed ID: 29420104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.
    Moi L; Hamedani M; Ribi C
    Clin Endocrinol (Oxf); 2022 Sep; 97(3):363-370. PubMed ID: 34908176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of corticosteroid-resistant Graves' orbitopathy with tocilizumab: a single-centre prospective study.
    Dorado Cortez O; Grivet D; Perrillat N; Gain P; Thuret G
    Orbit; 2023 Aug; 42(4):411-417. PubMed ID: 36065465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients.
    Sánchez-Bilbao L; Martínez-López D; Revenga M; López-Vázquez Á; Valls-Pascual E; Atienza-Mateo B; Valls-Espinosa B; Maiz-Alonso O; Blanco A; Torre-Salaberri I; Rodríguez-Méndez V; García-Aparicio Á; Veroz-González R; Jovaní V; Peiteado D; Sánchez-Orgaz M; Tomero E; Toyos-Sáenz de Miera FJ; Pinillos V; Aurrecoechea E; Mora Á; Conesa A; Fernández-Prada M; Troyano JA; Calvo-Río V; Demetrio-Pablo R; González-Mazón Í; Hernández JL; Castañeda S; González-Gay MÁ; Blanco R
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32878150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Treatment Strategies for Graves' Orbitopathy.
    Genere N; Stan MN
    Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
    Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
    Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab in glucocorticoid-resistant graves orbitopathy. A case series report of a mexican population.
    Ceballos-Macías José J; Rivera-Moscoso R; Flores-Real Jorge A; Vargas-Sánchez J; Ortega-Gutiérrez G; Madriz-Prado R; Velasco-Ramos PC; Muñoz-Monroy Omar E; Meneses-Pérez Anna C; Fernández-Morales Irma N; Hernández-Moreno A
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):78-82. PubMed ID: 32340849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency and Safety of Tocilizumab for the Treatment of Thyroid Eye Disease: A Systematic Review.
    Duarte AF; Xavier NF; Sales Sanz M; Cruz AAV
    Ophthalmic Plast Reconstr Surg; 2024 Jul-Aug 01; 40(4):367-373. PubMed ID: 38215463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
    Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography.
    de-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Troyano-Rivas J; Niño-Rueda C; Romo-López Á; Gómez-de-Liaño R
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Aug; 93(8):386-391. PubMed ID: 29937157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review.
    Calvo-Río V; de la Hera D; Beltrán-Catalán E; Blanco R; Hernandez M; Martínez-Costa L; Loricera J; Cañal J; Ventosa J; Ortiz-Sanjuán F; Pina T; González-Vela MC; Rodríguez-Cundín P; González-Gay MA
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S54-7. PubMed ID: 25005576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
    Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab treatment for refractory uveitis-related cystoid macular edema.
    Adán A; Mesquida M; Llorenç V; Espinosa G; Molins B; Hernández MV; Pelegrín L
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2627-32. PubMed ID: 23893042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis.
    Sepah YJ; Sadiq MA; Chu DS; Dacey M; Gallemore R; Dayani P; Hanout M; Hassan M; Afridi R; Agarwal A; Halim MS; Do DV; Nguyen QD
    Am J Ophthalmol; 2017 Nov; 183():71-80. PubMed ID: 28887113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Graves' ophthalmopathy.
    González-García A; Sales-Sanz M
    Med Clin (Barc); 2021 Feb; 156(4):180-186. PubMed ID: 33069387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].
    Nowak M; Marek B; Kos-Kudła B; Siemińska L; Londzin-Olesik M; Głogowska-Szeląg J; Nowak W; Kajdaniuk D
    Endokrynol Pol; 2022; 73(4):756-777. PubMed ID: 36059167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
    Bartalena L; Kahaly GJ; Baldeschi L; Dayan CM; Eckstein A; Marcocci C; Marinò M; Vaidya B; Wiersinga WM;
    Eur J Endocrinol; 2021 Aug; 185(4):G43-G67. PubMed ID: 34297684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.